2
Announcements
Trials
Browse
Landscape
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
5
Polycythemia Vera
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Myeloproliferative Disorders
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Lymphoma
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Adenocarcinoma
2
Urticaria
1
Tuberous Sclerosis
1
Thymic aplasia
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Sarcoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Pancreatitis, Chronic
1
Interventions
Infliximab
5
Certolizumab Pegol
5
Adalimumab
3
Nivolumab
2
MEDI2070
2
Educational Status
2
CT-P13
2
vedolizumab
1
secukinumab
1
golimumab
1
cabozantinib
1
Vitamin E
1
Vaccines
1
Ustekinumab
1
Sutures
1
Surveys and Questionnaires
1
Surgical Instruments
1
Standard of Care
1
Specimen Handling
1
Soybean Oil
1
Saline Solution
1
Ringer's Lactate
1
Proctocolectomy, Restorative
1
Practice Guidelines as Topic
1
Pneumococcal Vaccines
1
Platinum Compounds
1
Photoplethysmography
1
Phlebotomy
1
Papillomavirus Vaccines
1
Methoxsalen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Crohn Disease
×
Phlebotomy
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled